|
| | Publication Year | Title | Author(s) |
| 421 | 2020 | Idronoxil as an Anticancer Agent: Activity and Mechanisms. | Porter, Kate; Fairlie, Walter Douglas ; Laczka, Olivier; Delebecque, Frederic; Wilkinson, John |
| 422 | 1-Apr-2002 | IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells. | Luft, Thomas; Luetjens, Petra; Hochrein, Hubertus; Toy, Tracey; Masterman, Kelly-Anne; Rizkalla, Mark; Maliszewski, Charlie; Shortman, Ken; Cebon, Jonathan S ; Maraskovsky, Eugene |
| 423 | Aug-2021 | The IHC4+C score: an affordable and reproducible non-molecular decision-aid in hormone receptor-positive breast cancer. Does it still hold value for patients in 2020? | Harel, Nadav; Cheema, Steven ; Williams, David S ; Ireland-Jenkin, Kerryn ; Fancourt, Tineke ; Dodson, Andrew; Yeo, Belinda |
| 424 | 15-Jan-2002 | IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. | Luft, Thomas; Jefford, Michael; Luetjens, Petra; Hochrein, Hubertus; Masterman, Kelly-Anne; Maliszewski, Charlie; Shortman, Ken; Cebon, Jonathan S ; Maraskovsky, Eugene |
| 425 | 21-Jun-2019 | IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization. | Eissmann, Moritz F ; Dijkstra, Christine ; Jarnicki, Andrew; Phesse, Toby; Brunnberg, Jamina; Poh, Ashleigh R; Etemadi, Nima; Tsantikos, Evelyn; Thiem, Stefan; Huntington, Nicholas D; Hibbs, Margaret L; Boussioutas, Alex; Grimbaldeston, Michele A; Buchert, Michael; O'Donoghue, Robert J J; Masson, Frederic; Ernst, Matthias |
| 426 | Jul-2022 | IL-36G promotes cancer-cell intrinsic hallmarks in human gastric cancer cells. | Le, Ngan; Luk, Ian; Chisanga, David; Shi, Wei; Pang, Lokman; Scholz, Glen; Mariadason, John M ; Ernst, Matthias ; Huynh, Jennifer |
| 427 | 3-Jul-2020 | IL33 and Mast Cells-The Key Regulators of Immune Responses in Gastrointestinal Cancers? | Eissmann, Moritz F ; Buchert, Michael; Ernst, Matthias |
| 428 | 2021 | IL6 Signaling in Cancer: Not Always Bad News. | Huynh, Jennifer; Ernst, Matthias |
| 429 | 24-Mar-2020 | Imaging of neuroinflammation in adult Niemann-Pick type C disease: A cross-sectional study. | Walterfang, Mark; Di Biase, Maria A; Cropley, Vanessa L; Scott, Andrew M ; O'Keefe, Graeme J; Velakoulis, Dennis; Pathmaraj, Kunthi ; Ackermann, Uwe ; Pantelis, Christos |
| 430 | 1-Jun-2022 | Imaging Response to Contemporary Immuno-oncology Combination Therapies in Patients With Metastatic Renal Cell Carcinoma. | Navani, Vishal; Ernst, Matthew; Wells, J Connor; Yuasa, Takeshi; Takemura, Kosuke; Donskov, Frede; Basappa, Naveen S; Schmidt, Andrew ; Pal, Sumanta K; Meza, Luis; Wood, Lori A; Ernst, D Scott; Szabados, Bernadett; Powles, Thomas; McKay, Rana R; Weickhardt, Andrew J ; Suarez, Cristina; Kapoor, Anil; Lee, Jae Lyun; Choueiri, Toni K; Heng, Daniel Y C |
| 431 | 2021 | Immune Checkpoint Inhibition With Chemoradiotherapy in Stage III Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis of Safety Results. | Balasubramanian, Adithya ; Onggo, James; Gunjur, Ashray ; John, Thomas ; Parakh, Sagun |
| 432 | 17-Jun-2014 | Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment. | Vella, Laura J; Andrews, Miles C; Behren, Andreas; Cebon, Jonathan S ; Woods, Katherine |
| 433 | 2017 | The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma. | Thapa, Bibhusal ; Salcedo, Adriana; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Ameratunga, Malaka; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon; Mitchell, Paul L R ; Watkins, D Neil; Boutros, Paul C; John, Thomas |
| 434 | May-2023 | Immune priming with avelumab and rituximab prior to R-CHOP in diffuse large B-cell lymphoma: the phase II AvR-CHOP study. | Manos, Kate ; Chong, Geoffrey ; Keane, Colm; Lee, Sze Ting ; Smith, Charmaine; Churilov, Leonid ; McKendrick, Joseph; Renwick, William; Blombery, Piers; Burgess, Melinda; Nelson, Niles Elizabeth; Fancourt, Tineke ; Hawking, Joanne; Lin, Wendi; Scott, Andrew M ; Barraclough, Allison ; Wight, Joel C ; Grigg, Andrew P ; Fong, Chun Yew ; Hawkes, Eliza A |
| 435 | 1-Aug-2003 | Immuno-PET for tumor targeting. | Lee, Fook-Thean; Scott, Andrew M |
| 436 | 1-May-2001 | Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. | Lee, Fook-Thean; Hall, C; Rigopoulos, Angela; Zweit, J; Pathmaraj, K ; O'Keefe, Graeme J; Smyth, Fiona E; Welt, S; Old, Lloyd J; Scott, Andrew M |
| 437 | 14-Jun-2004 | Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. | Chen, Qiyuan; Jackson, Heather M; Parente, Phillip; Luke, Tina; Rizkalla, Mark; Tai, Tsin Yee; Zhu, He-Cheng; Mifsud, Nicole A; Dimopoulos, Nektaria; Masterman, Kelly-Anne; Hopkins, Wendie; Goldie, Heather; Maraskovsky, Eugene; Green, Simon; Miloradovic, Lena; McCluskey, James; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan |
| 438 | 23-Jun-2011 | Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™. | Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan S |
| 439 | 22-Feb-2005 | Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma. | Scott, Andrew M ; Liu, Zhanqi; Murone, Carmel ; Johns, Terrance G; MacGregor, Duncan; Smyth, Fiona E; Lee, Fook-Thean; Cebon, Jonathan S ; Davis, Ian D; Hopkins, Wendie; Mountain, Angela J; Rigopoulos, Angela; Hanai, Nobuo; Old, Lloyd J |
| 440 | Apr-2021 | Immunomodulatory effects of G-CSF in cancer: Therapeutic implications. | Mouchemore, Kellie A; Anderson, Robin L |
